M&A Deal Summary |
|
|---|---|
| Date | 2019-12-03 |
| Target | Ondal Group |
| Sector | Medical Products |
| Buyer(s) | IK Partners |
| Sellers(s) | Capvis |
| Deal Type | Secondary Buyout |
| Advisor(s) | William Blair (Financial) Hengeler Mueller (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Private Equity Firm |
|---|---|
| Founded | 1989 |
| PE ASSETS | 14.0B EUR |
| Size | Mega |
| Type | Sector Agnostic |
Ik Investment Partners Ltd. (Formerly Industri Kapital) is a private equity firm that targets control investments in mid-sized manufacturing and service companies located in select European countries. IK focuses on growth businesses located in the Benelux region, as well as Denmark, Finland, France, Germany, Norway and Sweden. The firm looks to commit €50 to €150 million of equity capital per transaction and targets companies with 'a proven ability to generate significant cash flow' as well as an ability to 'sustain growth through various economic cycles'. IK Investment Partners was formerly known as Industry Kapital. IK Investment Partners was formed in 1989 and has offices in Hamburg, London, Paris, and Stockholm.
| DEAL STATS | # |
|---|---|
| Overall | 134 of 170 |
| Sector (Medical Products) | 7 of 7 |
| Type (Secondary Buyout) | 45 of 64 |
| Country (Germany) | 21 of 27 |
| Year (2019) | 7 of 8 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-11-26 |
Mabtech
Nacka Strand, Sweden Mabtech is a biotech company specialising in immune monitoring products used by companies and researchers on a global scale. Mabtech was founded in 1986 and is based in Nacka Strand, Sweden. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-12-19 |
Cerelia
Paris, France Cerelia is a provider of innovative bakery solutions with a product portfolio including ready-to-bake pie and pizza dough, pancakes, crepes, and cookies. Cerelia was founded in 1999 and is based in Paris, France. |
Sell | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 1990 |
| PE ASSETS | 3.9B EUR |
| Size | Large |
| Type | Sector Agnostic |
Capvis Equity Partners is a Swiss-based private equity firm focused on buyout, succession, and expansion investments in Switzerland, China, and Germany. Sectors of interest include Healthcare, Industrial Technology, and Advanced Services & Software. Capvis will consider both majority and minority positions. The Firm's investment horizon is four to six years. Capvis Equity Partners was formed in 1990 and is headquartered in Baar with additional offices in Germany and China.
| DEAL STATS | # |
|---|---|
| Overall | 32 of 34 |
| Sector (Medical Products) | 2 of 2 |
| Type (Secondary Buyout) | 7 of 7 |
| Country (Germany) | 7 of 8 |
| Year (2019) | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-05-15 |
Xovis
Zollikofen, Switzerland Xovis is a high-tech company that develops and commercializes systems and sensors for people counting, tracking and similar applications. Xovis solutions are used for the optimised control of passenger flows and waiting times, for example at airports or in stationary retail. Xovis was founded in 2008 and is based in Zollikofen, Switzerland. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-12-13 |
Tertianum
Zurich, Switzerland Tertianum is an elderly care service provider in Switzerland offering inpatient care as well as assisted living services. The company has 80 locations, with approx. 3'400 care beds and more than 2'000 apartments for assisted living. Tertianum offers several specialized care services, such as dementia, geriatric care, palliative care, or other therapies. Tertianum was founded in 1982 and is based in Zurich, Switzerland. |
Buy | - |
